Fermi shares jump ~14% on AMD credit support deal
Fermi Inc shares rose 14.46% after an AMD credit support deal backed Phase 1 of its Project Matador data-centre build in Texas.
Markets
Delayed · 01:07 UK
Financial News
Martin Holloway spent the better part of two decades on bank trading floors in the City before he started filing copy. He read Economics at a redbrick university, joined a graduate scheme at one of the UK clearers in the late 1990s, and moved across to fixed income early in his career. The bulk of his time was on macro desks at European banks, running short-end and cross-asset positions through the 2008 crisis and the long grind of the post-crisis rates regime. He stepped off the desk toward the end of the last decade, did a stint consulting on the buy side, and started writing in 2020. He covers the bits of the City he actually knows: rates, FX, UK banks, gilt issuance, and the corporate news that moves them. He has a working theory about why nobody on the sell side saw the 2022 gilt crisis coming, and is happy to share it at moderate length. Martin lives in the South East with his family. He reads the FT in the morning out of habit rather than affection, and treats most market commentary as marketing collateral written by people who have never held risk overnight.
Covers
101–110 of 690
Fermi Inc shares rose 14.46% after an AMD credit support deal backed Phase 1 of its Project Matador data-centre build in Texas.
Wells Fargo Q3 earnings beat on profit with EPS of $1.87, but revenue missed estimates and the shares fell despite loan growth.
Zimmer Biomet's distribution agreement with THINK Surgical for the TMINI robotic knee system has been extended for multiple years, the firms confirmed.
Accenture has acquired Sagacity to scale AI-driven customer intelligence across its UK and Ireland operations, adding 140+ specialists.
Applied Materials opened its EPIC Center Silicon Valley R&D hub on 12 October 2026, but the $5bn figure is a scaling ceiling, not spent capital.
CCC Intelligent Solutions buyout talks with GTCR and Elliott sent shares up as much as 8% Monday, extending a Friday rally.
Bristol Myers Squibb's admilparant Phase 3 trial met its primary endpoint in IPF, but only the 60mg dose reached significance, filings show.
Flex expands its modular data centre portfolio with AI Modules it says cut build times 50%, days after a $2bn deal to back the Axiom spin-off.
STERIS's $2.1bn Xodus Medical acquisition adds operating-room products, but the deal's EBIT math leans on a one-off add-back.
Marvell launched its second-gen Structera X CXL memory expander for AI inference on 12 October, even as MRVL shares fell 3.47% on the day.
Page 11 of 69